The global cell separation technologies market reached a value of US$ 7.62 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 19.28 Billion by 2027, exhibiting a CAGR of 16.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cell separation technologies are a set of techniques, which are extensively deployed for identifying and separating one or more cells from the heterogeneous mixture based on their extracellular properties. They are further utilized in the healthcare sector for dealing with various chronic diseases, such as cancer, acquired immune deficiency syndrome (AIDS) and cystic fibrosis. Some of the most employed techniques for cell separation include microfluidic cell sorting, immunogenicity cell isolation and density gradient configuration. These techniques are applied based on the varying size, density, surface protein expression and shape of the cells.
Cell Separation Technologies Market Trends: The widespread adoption of cell separation technologies in the pharmaceutical industry to enhance drug discovery and develop drugs with improved efficacies is one of the key factors driving the global cell separation technologies market toward growth. Additionally, the introduction of advanced isolation tools for the continuous examination of nucleic acids, chromatin, proteins, and other complex cells is contributing to the market growth. In line with this, the increasing requirement for personalized medicines and an enhanced focus on cell-based research are positively impacting the market growth. Moreover, the increasing investments and fundings in the research and development (R&D) activities in the field of biotechnology for developing and utilizing isolated cells for developing novel cell-based treatments and therapies for several chronic ailments is propelling the market growth. Furthermore, the escalating prevalence of various chronic diseases amongst the geriatric population is positively influencing the market. Other factors, such as the rapid expansion in the pharmaceutical and biotechnology industry and the numerous initiatives undertaken by the governments of several nations for fortifying the healthcare infrastructure by enhancing cell-based technology, are creating a positive outlook for the market.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global cell separation technologies market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, cell type, technology, application and end user.
Breakup by Application: Oncology Research Neuroscience Research Stem Cell Research Microbiology Immunology Research Others
Breakup by End User: Research Laboratories and Institute Biotechnology and Biopharmaceutical Companies Cell Banks
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report: How has the global cell separation technologies market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global cell separation technologies market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the cell type? What is the breakup of the market based on the technology? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global cell separation technologies market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The product design and development services market is expected to grow from US$ 9,519.97 million in 2022 to US$ 17,663.12 million by 2028; it is expected to grow at a CAGR of 10.9% from 2022 to 2028. Technological advancements and high demand for quality products in healthcare due to rising health concerns among the geriatric population...
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...
532 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
The global carbon dioxide incubators market reached a value of US$ 651 Million in 2021. Looking forward, the analyst expects the market to reach US$ 942.4 Million by 2027, exhibiting a CAGR of 6.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct...
The global compressed air treatment equipment market reached a value of US$ 8.26 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 12.05 Billion by 2027, exhibiting a CAGR of 6.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as...
215 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
The global synthetic biology market is expected to grow at a CAGR of 25% during 2022-2027. Synthetic biology is a new interdisciplinary field that includes the application of engineering principles to biology. It intends to design and manufacture biological components and systems that do not yet exist in nature. Synthetic biology combines...
The research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility,...
The Global Antibody Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
The global manufacturing operations management software market reached a value of US$ 9.5 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 17.5 Billion by 2027, exhibiting a CAGR of 11% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
Chronic Disease
Advanced IT
Research And Development
Industrial Control System
Artificial Intelligence
Manufacturing
Aerospace And Defense
Software
Food Safety
Pharmaceutical
Health Services
World
Chronic Disease Prevalence
Manufacturing Output
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.